𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of childbirth after treatment on long-term survival from breast cancer

✍ Scribed by H. M. Verkooijen; G. H. Lim; K. Czene; V. Bhalla; K. Y. Chow; K. P. L. Yap; K. S. Chia; M. Hartman


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
124 KB
Volume
97
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

This study quantified long-term absolute and relative mortality risks of survivors of breast cancer with subsequent childbirth.

Methods

The Singapore Birth Register (n = 319 437), Swedish Multi-Generation Register (n = 11 million) and population-based cancer registries were linked to identify 492 women with childbirth after breast cancer. For these women, cumulative mortality risks and standardized mortality ratios (SMRs) were calculated and compared with those of 8529 women aged less than 40 years with breast cancer without subsequent childbirth, and with those predicted by Adjuvant! Online.

Results

Women with subsequent childbirth had a lower 15-year cumulative overall mortality rate than other women with breast cancer (16Β·8 (95 per cent confidence interval (c.i.) 13Β·3 to 20Β·9) versus 40Β·7 (39Β·5 to 41Β·9) per cent), but a higher relative mortality risk than the background population (SMR 13Β·6, 95 per cent c.i. 10Β·6 to 17Β·3). Mortality risks decreased significantly with increasing interval between diagnosis and subsequent childbirth. Mean 10-year cumulative mortality risks of women with subsequent childbirth were within the range of 10-year mortality predicted by Adjuvant! Online for women with T1 N0 tumours in otherwise perfect health.

Conclusion

This study reinforced the view that pregnancy after breast cancer is not detrimental to survival. However, women who gave birth after this diagnosis had substantially higher mortality risks than young women in the general population. This information may be a valuable addition to routine mortality estimates.


πŸ“œ SIMILAR VOLUMES


Long-term inhibitory effect of the orall
✍ Steeve Couillard; Claude Labrie; Sylvain Gauthier; Yves Merand; Shankar Mohan Si πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 174 KB πŸ‘ 2 views

The antiproliferative effect of the new antiestrogen EM-800 has been studied during 40 weeks of treatment on human breast carcinoma ZR-75-1 xenografts in ovariectomized nude mice supplemented with estrone (0.5 g, s.c. daily). At the daily 50 g (approximately 2.5 mg/kg) oral dose, EM-800 caused a com

Long-term inhibitory effects of a novel
✍ Shouqi Luo; CΓ©line Martel; Sylvain Gauthier; Yves MΓ©rand; Alain BΓ©langer; Claude πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 83 KB πŸ‘ 2 views

The effects of the novel anti-estrogen EM-343 on the growth of 2 hormone-responsive human breast cancer tumors have been examined in athymic nude mice. At the low daily dose of 5 g, EM-343 administered subcutaneously for 6 months completely blocked the stimulatory effect of endogenous estrogens on t